Back
Photronics 10K Form
Sell
46
PLAB
Photronics
Last Price:
23.00
Seasonality Move:
22.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-06-07 | 10Q | PLAB/Photronics Quarterly |
| 2024-03-07 | 10Q | PLAB/Photronics Quarterly |
| 2023-09-07 | 10Q | PLAB/Photronics Quarterly |
| 2023-06-08 | 10Q | PLAB/Photronics Quarterly |
| 2023-03-09 | 10Q | PLAB/Photronics Quarterly |
| 2022-09-07 | 10Q | PLAB/Photronics Quarterly |
Receive PLAB News And Ratings
See the #1 stock for the next 7 days that we like better than PLAB
PLAB Financial Statistics
Sales & Book Value
| Annual Sales: | $892.08M |
|---|---|
| Cash Flow: | $50.66M |
| Price / Cash Flow: | 9 |
| Annual Sales: | $17.27 |
| Price / Book: | 1.37 |
Profitability
| EPS (TTM): | 2.27000 |
|---|---|
| Net Income (TTM): | $141.43M |
| Gross Margin: | $336.16M |
| Return on Equity: | 10.62% |
| Return on Assets: | 9% |
Photronics Earnings Forecast
Key Photronics Financial Ratios
- The Gross Profit Margin over the past 39 years for PLAB is 37.68%.
- The Selling, General & Administrative Expenses for PLAB have been equal to 7.79% of Gross Profit Margin.
- The Research & Development expenses have been 1.53% of Revenue.
- The Interest Expense is 0.35% of Operating Income.
- The Net Earning history of PLAB is 14.07% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 23 years.
Photronics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Semiconductors & Semiconductor Equipment |
| Sector: | Information Technology |
| Current Symbol: | PLAB |
| CUSIP: | 719405 |
| Website: | photronics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.67 |
| Quick Ratio: | 4.22 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.34 |
|---|---|
| Forward P/E Ratio: | 0 |
PLAB Technical Analysis vs Fundamental Analysis
Sell
46
Photronics (PLAB)
is a Sell
Is Photronics a Buy or a Sell?
-
Photronics stock is rated a Sell
The current Photronics [PLAB] share price is $23.03. The Score for PLAB is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.